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Th17 cells play a key role in the progression of coxsackievirus B3 (CVB3)-induced acute
viral myocarditis (AVMC). However, the direct effect of virus on Th17 cell differentiation
is still unknown. Recently, nucleoporin (Nup) 98 has been proved to be associated with
lymphocyte differentiation. Therefore, we investigated whether Nup98 mediated Th17
cell differentiation in AVMC. In our study, patients with AVMC and healthy controls were
recruited. The results showed that CVB3 could enter into the CD4+ T cells in AVMC
patients and healthy controls. After transfecting purified CD4+ T cells with CVB3 in vitro,
the Th17 cell frequency, IL-17 secretion, and RORγT synthesis were increased while
the Nup98 levels were decreased. Furthermore, down-regulating Nup98 expression by
siRNA-Nup98 in CD4+ T cells resulted in the elevated Th17 cell frequency and IL-17
secretion, along with enhanced levels of RORγT, dissociative p300/CBP, and acetylated
Stat3. Up-regulation of Nup98 expression by pcDNA3.1-Nup98 showed the opposite
effects. Our results suggested that CVB3 directly induced CD4+ T cell differentiation into
Th17 cells by inhibiting Nup98 expression, representing a therapeutic target in AVMC.
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INTRODUCTION
Acute viral myocarditis (AVMC) is triggered by viral infection and is characterized by myocardial
inflammation, which progresses to chronic dilated cardiomyopathy (DCM) and heart failure
(Dennert et al., 2008). Frequency of myocarditis has been reported to range from a low of 4–5% in
young men dying of trauma to a high of 16–21% in children succumbing to sudden death (Gauntt
andHuber, 2003). Coxsackievirus B3 (CVB3) is themost commonly identified cause of myocarditis
and has been linked to the ensuing development of dilated cardiomyopathy (Esfandiarei and
McManus, 2008; Andréoletti et al., 2009; Fairweather et al., 2012). CD4+ Th17 cells promote the
development of AVMC by facilitating viral replication, inflammation and autoantibody production
(Yuan et al., 2010a,b). Previous studies revealed that viral infection induced the activation of
innate immune cells such as macrophages and dendritic cells (DCs), which indirectly contribute to
Th17 cell differentiation by secreting inflammatory cytokines and generating co-stimulatary signals
(Fairweather et al., 2005; Huang and Yang, 2009; Yajima and Knowlton, 2009; Rose, 2011). However,
the direct effect of virus on Th17 cell differentiation is still unknown.
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Nuclear pore complexes (NPCs) are multi-protein aqueous
channels connecting the nucleus and cytoplasm, mediating cell
differentiation (Raices and D’Angelo, 2012). NPCs consist of
nearly 30 different proteins called nucleoporins (Nups) (Kalverda
and Fornerod, 2007). Among the Nups, Nup98 is associated with
mRNA export pathway induced by viruses (Enninga et al., 2002).
Enninga et al. have shown that vesicular stomatitis virus (VSV)
matrix (M) contributes to Nup98 expression and directly induces
antiviral cytokine IFN-γ generation by inhibiting messenger
RNA (mRNA) nuclear export (Enninga et al., 2002). Therefore,
we investigated the role of Nup98 in virus-induced differentiation
of Th17 cells in AVMC patients.
MATERIALS AND METHODS
Patients
A total of 21 patients at the Union Hospital, Huazhong
University of Science and Technology were diagnosed with
AVMC and enrolled in our study from June 2014 to
January 2015. All of them had developed symptoms associated
with heart within 3 weeks after viral infection such as
upper respiratory tract infection and diarrhea. The diagnosis
was established according to the “Reference standards for
diagnosis of acute viral myocarditis in adults” recommended by
Committee of Task Force on Myocarditis and Cardiomyopathy
of Chinese Journal of Cardiology Editor (1999), which was
consistent with the recommendations of the 6th edition of
Braunwald’s Heart Disease (Wynne and Braunwald, 2001). In
addition, all the patients diagnosed with AVMC exhibited
a mild increase in creatine kinase (CK) MB or cardiac
troponin I (cTNI) at the time of enrollment. The plasma of
all the AVMC patients tested CVB3-IgM positive (Patients
with CVB5-IgM positive, Cytomegalovirus-IgM positive and
Parvovirus B19-IgM positive were all excluded from our
study). Patients with other acute or chronic diseases were
excluded and no patient was treated with nonsteroidal anti-
inflammatory drugs or immunosuppressors. Furthermore, 23
volunteers were recruited as controls in the study. This
study was first conducted in accordance with the tenets
of the Declaration of Helsinki and its amendments and
was subsequently approved by The Ethics Committee of
Tongji Medical College, Huazhong University of Science and
Technology, China (IORG No: IORG0003571). Each recruit
provided signed informed consent.
Blood Samples
Blood samples were obtained from all the patients and
healthy controls in the recumbent position under fasting
state the next morning of hospitalization. The blood samples
were stored in vacutainer tubes containing 3.2% sodium
citrate. Each blood sample was centrifuged at 2000 rpm for
15min. The plasma was collected for cytokine measurement.
The blood cells were layered over Ficoll-Hypaque density
gradient solution to separate peripheral blood mononuclear
cells (PBMCs) for flow cytomentry, magnetic cell sorting,
real time-polymerase chain reaction (RT-PCR) and Western
blot.
ELISA
The plasma levels of IL-17 were measured using the enzyme-
linked immunosorbent assay (ELISA) kit (ebioscience),
according to the manufacturer’s instructions. The ELISA kit
showed a sensitivity of 1.6 pg/mL. All the samples were analyzed
in triplicate.
Immunoturbidimetric Assay
Plasma hsCRP (hypersensitive C reactive protein) were
measured by Beckman AU 5800 using immunoturbidimetric
assay (Beckman Coulter Inc) according to the manufacturer’s
instructions. The sensitivity of hsCRP was 0.11 mg/L (Karaca
et al., 2016).
Isolation of Human CD4+ T Cells
The peripheral blood cells obtained from healthy controls
and AVMC patients were layered over Ficoll-Hypaque density
gradient solution (Sigma) in order to obtain mononuclear cells.
The CD4+ T cells were purified by negative selection using
human CD4+ T cell isolation kit (Miltenyi Biotech) according to
the manufacturer’s protocol. Briefly, PBMCs were incubated with
CD4+ T cell biotin-antibody cocktail (10µl/107cells) for 5min,
followed by anti-biotin microbeads (40µl/107cells) for 10min
at 4◦C. After washing with MACS buffer, the re-suspended cells
were loaded on an LS column (Miltenyi Biotech) to obtain the
purified CD4+ T cells (purity> 95%).
CVB3-Infected CD4+ T Cells
The CD4+ T cells from healthy controls were cultured at 5 ×
105 cells/mL for 12 h at 37◦C in six-well plates (Costar). For
experimental infections, cells were washed once with serum-free
1640 medium (Hyclone). The 0.1 mL 1640 medium containing
CVB3 (CCTCC, GDV115, 5 × 105 plaque forming unit
(PFU)/mL) was added to CVB3 group, and 0.1mL 1640 medium
without virus was added to the mock group. This system was
cultured for 2 h in 1 mL serum-free 1640 medium. After washing,
cells were cultured with 1640 medium containing 5% FBS,
5µg/mL of anti-CD3 (ebioscience), 2µg/mL soluble anti-CD28
(eBioscience), 10µg/mL anti-IL-4 (ebioscience), and 10µg/mL
anti-IFN-γ (ebioscience) for 5 days at room temperature. The
cells and culture supernatants were harvested for further analysis.
The virus experiment was performed according to the general
requirements for laboratory biosafety (GB 19489-2008) in China.
Plaque-Forming Assay
105 CD4+ T cells were homogenized in 1mL 1640 medium. The
virus was released from the cells following freeze-thaw cycles
and the supernatant was obtained. The HeLa cell monolayers
(70% confluency) were incubated with supernatants of infected
CD4+ T cells for 2 h at 37◦C and 5% CO2, in 24-well plates.
After washing with PBS, plates were covered with a 3mL mix
of 0.3% agar, 1640, and 5% FBS. After 72 h of cultivation, the
monolayers were fixed and stained in neutral red, and the plaques
were counted. Viral titers were determined using standard plaque
formation assay.
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Transfection
After isolation, the purified CD4+ T cells from AVMC
patients were transferred into 1640 medium with 10%
FBS at a density of 3 × 106 cells /mL in a 12-well culture
plate (Corning) and cultured at 37◦C/5% CO2. They were
transfected with 200 nM siRNA-Nup98 (IBS company,
sense: GGAUGACCGAGAAGAAAUAGA, antisense:
UAUUUCUUCUCGGUCAUCCUG) or 4µg pcDNA3.1-
Nup98 plasmid (IBS company) using the Amaxa human
T-cell nucleofector kit (Lonza Cologne AG) via V24
program according to the manufacturer’s instructions. 4µg
pmaxGFP R© Vector was transfected into 3 × 106 CD4+
T cells by necleofection. The transfection efficiency was
evaluated by flowcytometry. After transfected 12 h, green
fluorescent protein (GFP) expression was checked to show
the efficiency. The nonsilencing control (NC) siRNA (IBS
company, sense: UUCUCCGAACGUGUCACGUTT, antisense:
ACGUGACACGUUCG GAGAATT) or empty pcDNA3.1
(IBS company) was transfected into CD4+ T cells as control.
Cells were then stimulated with 5 × 104 PFU/mL CVB3,
5µg/mL of anti-CD3 (ebioscience), 2µg/mL soluble anti-CD28
(eBioscience), 10µg/mL anti-IL-4 antibody (ebioscience), and
10µg/mL anti-IFN-γ antibody (ebioscience). After 72 h of
incubation, cells and supernatants were collected, respectively,
for further study.
Flow Cytometry
The PBMCs or CD4+ T cells were re-suspended to approximately
2 × 106 cells in 100µL ice-cold PBS. Fluorescein isothiocyanate
TABLE 1 | Clinical Characteristics of AVMC Patients and Healthy controls.
Characteristics Healthy controls
(n = 23)
AVMC patients
(n = 21)
Age (year) 36 ± 5 34 ± 17
Gender (Male:Female) 9:14 8:13
Hospital stays (day) 0(0) 9 ± 4
MAJORORGAN INVOLVEMENT
Pulmonary. No (%) 0(0) 5(23.8)
Kidney. No (%) 0(0) 3(19)
Liver. No (%) 0(0) 0(0)
NYHA CLASSIFICATION
I. No (%) 0(0) 7(33.3)
II. No (%) 0(0) 8(38.1)
III. No (%) 0(0) 0(0)
IV. No (%) 0(0) 0(0)
MEDICATIONS
ACEI/ARBs. No (%) 0(0) 10(47.6)
β-blockers. No (%) 0(0) 18(85.7)
Calciumchannelblockers. No (%) 0(0) 7(33.3)
Nitrates. No (%) 0(0) 3(19.0)
Aldactone. No (%) 0(0) 19(90.47)
CoQ10. No (%) 0(0) 21(100)
Diuretica. No (%) 0(0) 7(33.3)
hsCRP (mg/L) 0.49 ± 0.15 5.21 ± 1.68
IL-17 (ng/ml) 26.39 ± 4.88 92.2 ± 8.99
(FITC)-labeled anti-human CD4 antibody (Biolegend) was
added to each tube along with Phycoerythrin-Cy7 (PE-CY7)
anti-human CD45RO antibody (BD biosciences). The cells were
incubated for 30 min at 4◦C in the dark. After washing with PBS,
these cells were stimulated with 1µg/mL ionomycin, 20 ng/mL
phorbol myristate acetate (PMA), and 2µmol/L monensin (all
from eBioscience) for 5 h under a 5% CO2 /37
◦C environment in
a 24-hole culture plate (Costar). After 5 h, cells were harvested
and washed with PBS. They were fixed and permeabilized by
FACSTM Perm 2 (BD Bioscience) according to the manufacturer’s
instructions. For intracellular staining, the cells were stained
with phycoerythrin (PE)-labeled anti-human IL-17 antibody (BD
biosciences) for 30 min. After washing with PBS, these cells were
FIGURE 1 | The virus detection in CD4+ T cell from AVMC patients. (A)
The CVB3 titers of purified CD4+ T cells isolated from peripheral blood in
healthy controls and AVMC patients. (B) The levels of CVB3 mRNA in CD4+ T
cell isolated from peripheral blood were higher in AVMC patients than those in
healthy controls (p < 0.001). Values are means ± SEM. **P < 0.01 vs. Healthy
controls.
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re-suspended with 200µL PBS in tube, respectively. After adding
10µl CountBrightTM Absolute Counting Beads (Thermo Fisher)
into each tube, samples were measured by FACS calibur flow
cytometry (BD Biosciences).
Western Blot
The total proteins in PBMCs or CD4+ T cells were extracted
using the Total Protein Extraction Kit (Pierce/Thermo
Scientific). BCA Protein Assay Kit (Pierce) was used to
determine protein concentrations. Samples containing 60µg
protein were separated on 10% SDS-PAGE or 8% SDS-
PAGES and electrotransferred onto nitrocellulose membranes.
The membranes were blocked for 2 h in TBST containing
5% skim milk and then incubated with primary antibodies
at 4◦C overnight. The primary antibodies Nup98 (1:800,
Abcam), RORγT (1:500, Abcam), p300/CBP (1:500, Sigma),
Acetyl-Stat3 (1/500, Thermo scientific), Stat3 (1:1000, Cell
Signaling Technology), CAR (1:500, Santa Cruz), DAF (1:1000,
Abcam), and β-actin antibodies (1:1000, Millipore) were added,
respectively. After washing, the membranes were incubated
with HRP-conjugated secondary antibodies (1:3000, Jackson
ImmunoResearch) at 37◦C for 2 h. The target bands were
finally washed and developed with ECL reagent or super ECL
reagent (Thermo Scientific), and then captured using Image
Lab (Bio-Rad). Densitometric methods were used to analyze the
images.
Real-Time PCR
The total RNA was extracted from the cells using the
TRIzol reagent (Takara) following the protocol and
then reverse transcribed to cDNA. The sequences of
primer pairs were as follows: Nup98 (forward) 5′-
CTCCACCACTAATTCAGGCTTT-3′ and Nup98 (reverse)
5′-GAGGCTGGTAGTCTGCTGATT-3′; RORγT (forward)
5′-CAAAGCAGGAGCAATGGAAGTG-3′ and RORγT
(reverse) 5′-GGAGTGGGAGAAGTCAAAGATG-3′; IL-17
(forward) 5′-CCTCAGACTACCTCAACCGTTC-3′ and IL-17
(reverse) 5′-TTCATGTGGTGGTCCAGCTTTC-3′; β-actin
(forward) 5′-AAGGCCAACCGTGAAAAGAT-3′and β-actin
(reverse) 5′- GTGGTACGACCAGAGGCATAC-3′; CVB
(forward)5′-CGGTACCTTTGTGCGCCTGT-3′ and CVB
(reverse) 5′-CAGGCCGCCAACGCAGCC-3′. After an initial
denaturation step at 94◦C for 3min, 40 cycles were carried out,
each of which consisted of the following three steps: denaturation
at 94◦C for 30 s, annealing at 58◦C for 30 s, and extension at 72◦C
for 30 s. All the reactions were conducted at least in duplicate
for each sample. The gene expression was analyzed using the
real-time fluorescent quantitative PCR system (Bio-rad). The
level of gene expression was calculated by the 2−11Ct.
Statistical Analysis
Data were represented as the mean ± SEM. Statistical analysis
was conducted using a two-tailed Student’s t-test for two
groups and one-way ANOVA for more than two groups. Chi-
square test was performed for the categoric variables of clinical
characteristics. Bivariate correlation analysis was used as a test
of correlation between two variables. P < 0.05 was considered
statistically significant.
RESULTS
Viral Detection in CD4+ T Cells of AVMC
Patients
The clinical data of AVMC patients and healthy volunteers are
displayed in Table 1. No significant differences were found in age
and sex. Compared with healthy controls, the levels of plasma
hsCRP (P< 0.001) and IL-17 (P< 0.001) were higher in patients
with AVMC.
Purified CD4+ T cells isolated from the peripheral blood in
AVMC patient and healthy volunteer were collected for viral
detection. The data indicated that the average virus titer was 230
PFU/ml (105 cells homogenized in 1mL 1640medium) in AVMC
patients whereas no virus was detected in healthy volunteers (P<
0.001, Figure 1A). In addition, levels of CVB mRNA in CD4+ T
cell were higher in AVMC patients than those in healthy controls
(P < 0.001, Figure 1B). These data revealed that virus could be
detected in peripheral CD4+ T cells of AVMC patients.
Th17 Cell Frequencies and Nup98
Expression in AVMC Patients
To clarify the relationship between Th17 cell frequencies and
Nup98 expression, we performed flow cytometry and western
blot. Human naive and effector T cells can be identified
by CD4+CD45RO− T cells and CD4+CD45RO+ T cells
(Teteloshvili et al., 2015). As shown in Figure 2A, after gating
CD4 positive cells, we costained IL-17 with CD45RO and found
that the frequencies of CD45RO+ T cells were about 60%.
Furthermore, IL-17 was mostly secreted by CD4+ CD45RO+
effector T cells rather than CD4+ CD45RO− T cells. In PBMCs,
the frequencies of CD4+CD45RO+IL-17+ effector (Th17) cells
(P = 0.014) were increased in AVMC patients compared with
healthy volunteers (Figures 2A,B). By using counting beads, we
found that the absolute number of Th17 cells was also higher
in AVMC patients than that of healthy volunteers (P = 0.012,
Figure 2C). And the Th17 frequencies were positively correlated
with CVB3 virus titers in peripheral CD4+T cells of AVMC
patients (R= 0.505, P = 0.032, Figure 2D).
The Nup98 expression in purified CD4+ T cells was lower
(P = 0.018) in AVMC than in healthy volunteers (Figure 2E).
However, RORγT, the primary transcription factor of Th17 cell
demonstrated the contrary results (P = 0.033, Figure 2E). These
data indicated that Nup98 expressions were associated with Th17
cell frequencies in AVMC patients.
Direct Effects of CVB3 on Th17 Cell
Differentiation
The purified CD4+ T cells isolated from healthy volunteer blood
were collected andmock-infected or directly infected with CVB3.
After 5 days, the viral titer was detected. The data showed that the
average CVB3 titer was 3.1× 103 PFU/ml (105 cells homogenized
in 1 mL 1640 medium) in the CVB3 group while no plaque was
formed in the mock group (Figure 3A). The frequencies of Th17
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FIGURE 2 | Th17 cell frequencies and Nup98 expression in AVMC patients. (A) The CD4+ T cells were gated from PBMCs for further analysis. The
representative pictures for CD4+ CD45RO+ Th17 cell frequencies in healthy controls and AVMC patients. (B) The results of statistical analysis for Th17 cell
frequencies by flow cytometry between healthy controls and AVMC patients were shown in histogram. (C) The absolute numbers of Th17 cells (per ml blood) of
healthy controls and AVMC patients were shown in the histogram. (D) The correlation analysis between Th17 frequencies and virus titers in peripheral CD4+ T cells of
AVMC patients. (E) The representative pictures for Nup98 and RORγT protein expression with western blot analysis.Intensity of bands were normalized to β-actin and
shown in histogram. Values are means ± SEM. *P < 0.05 vs. Healthy controls.
FIGURE 3 | Direct effects of CVB3 on Th17 cell differentiation. (A) Upper: Representative pictures of plaque assay of mock-infected and CVB3-infected CD4+ T
cells from peripheral blood in healthy controls. Lower: The results of statistical analysis for plaque assays in mock and CVB3 groups. (B) Representative pictures for
Th17 cell frequencies in mock and CVB3 groups by flow cytometry. (C) Statistical analysis for Th17 frequencies was shown in histogram. (D) The cultural supernatant
IL-17 concentration in mock and CVB3 groups was measured by ELISA. (E) The mRNA levels of Nup98 and RORγT in CD4+ T cells. (F) The protein expression of
Nup98 and RORγT in CD4+ T cells. Values are means±SEM. *P < 0.05 vs. mock group; **P < 0.01 vs. mock group.
cells in CVB3 group were increased (P = 0.021) compared with
those in the mock group (Figures 3B,C). The IL-17 levels in the
supernatant (P = 0.013) showed similar changes (Figure 3D).
The mRNA (P= 0.009) and protein (P= 0.009) levels of RORγT
in the CVB3 group were enhanced compared with those in
the mock group (Figures 3E,F). However, the Nup98 mRNA
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FIGURE 4 | The expressions of CVB3 receptors on CD4+ T cells. (A) The expressions of CAR/DAF on nonactivated and activated CD4+ T cells were
investigated. 293T and CHO cell lines were used as the CAR/DAF -positive and -negative controls respectively. (B) The CAR was not expressed on both nonactivated
and activated CD4+ T cells (5µg/ml anti-CD3, 2µg/ml anti-CD28 stimulated for 3 days). The DAF was expressed on both nonactivated and activated CD4+ T cells,
but the expressions of DAF between nonactivated and activated CD4+ T cells showed no difference. (C) The representative pictures of plaque assay for purified
CD4+ T cells in mock, CVB3, CVB3+DAF mAb, CVB3+Isotype groups (all CD4+ T cells were isolated from peripheral blood in healthy controls). (D) The results of
statistical analysis for CVB3 titers in these four groups. Values are means ± SEM. **P < 0.01 vs. Mock group; #P < 0.05 vs. CVB3 and CVB3+Isotype groups.
(P = 0.040) and protein (P = 0.030) levels showed the opposite
changes (Figures 3E,F). From this, we found that CVB3 could
directly induced Th17 cell differentiation, which might be related
to the decreased Nup98 expression.
The Expression of CVB3 Receptors on
CD4+ T Cells
The expression of the primary receptor coxsackie-adenovirus
receptor (CAR) of CVB3 on CD4+ T cells was determined. The
cell lines 293T and Chinese hamster ovary (CHO) were used as
CAR positive and negative controls, respectively (Candolfi et al.,
2006). However, we found that neither nonactivated CD4+ T
cells nor activated CD4+ T cells expressed CAR (Figures 4A,B).
Decay-accelerating factor (DAF) is a binding receptor for CVB3.
The 293T cells and Chinese hamster ovary (CHO) cells were also
used as DAF-positive and -negative controls for DAF, respectively
(Bétis et al., 2003). The DAF could be detected on CD4+ T cells.
However, the expression of DAF showed no differences (P =
0.810) between nonactivated CD4+ T cells and activated CD4+
T cells (Figures 4A,B). To further investigate the role of DAF in
CVB3 infection, the 10 ug/ml anti-DAF monoclonal antibodies
(mAb, R&D), 10 ug/ml isotype control and 10 ul saline was
added in the culture system respectively. The data showed that
the CVB3 titer in CD4+ T cells treated with anti-DAF mAb was
significantly lower (P = 0.043) than those treated with saline and
isotype controls (Figures 4C,D). These data suggested that the
entry of CVB3 into human CD4+ T cells might be mediated by
DAF receptors rather than CAR.
Effect of Nup98 on Th17 Cell Differentiation
in AVMC
To further clarify the role of Nup98 in Th17 cell differentiation
in AVMC, the purified CD4+ T cells from AVMC patients were
transfected with empty pcDNA3.1, pcDNA3.1-Nup98, NCsiRNA
and siRNA-Nup98. The frequencies of Th17 cells were higher (P
= 0.043) in the Nup98-siRNA group but lower (P = 0.021) in
the pcDNA3.1-Nup98 group compared with those in pcDNA3.1
and NC groups (Figures 5A,B). Compared with pcDNA3.1 and
NC groups, the levels of Nup98 mRNA in pcDNA3.1-Nup98
group were enhanced (P = 0.010), while the Nup98 mRNA in
siRNA-Nup98 was reduced (P = 0.040, Figure 5D). The levels
of IL-17 in the supernatant, IL-17 mRNA and RORγT mRNA in
CD4+ T cells were altered in accordance with Th17 cells (all P
< 0.05, Figures 5D,E). The differences between NC and empty
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FIGURE 5 | Effects of Nup98 on Th17 cell differentiation in AVMC. CVB3 infected CD4+ T cells from peripheral blood in AVMC patients were transfected with
Nup98 siRNA or Nup98 cDNA by the Human T Cell Nucleofector Kit and cultured with anti-CD3, anti-CD28, anti-IL-4 and anti-IFN-γ for 72 h. (A) Representative
pictures of Th17 cell frequencies of CD4+ T cell in pcDNA3.1, NC, pcDNA3.1-Nup98, and siRNA-nup98 groups were listed. (B) The statistical analysis for Th17
frequencies was shown in histogram. (C) The GFP-transfection efficiency was detected by flow cytometry and a typical FACS picture was shown. (D) The mRNA
levels of Nup98, RORγT and IL-17 in CD4+ T cells of four groups. (E) The cultural supernatant IL-17 concentration was measured by ELISA. Data are shown as mean
± SEM. *P < 0.05, **P < 0.01 vs. pcDNA3.1 and NC groups. NC: Nonsilencing siRNA sense.
pcDNA3.1 groups were not statistically significant (Figure 5). As
a result, Th17 cell differentiation could be induced by down-
regulating Nup98 expression after CVB3 infection.
Nup98 Pathway in Th17 Differentiation
Compared with pcDNA3.1 and NC groups, the levels of
dissociative p300/CBP, acetylated-Stat3, and RORγT were
decreased along with the increased Nup98 expression in
pcDNA3.1-Nup98 group (all P < 0.05, Figure 6). Furthermore,
down-regulation of Nup98 expression resulted in opposite
changes. The differences between NC siRNA and pcDNA3.1
groups were not significant (Figure 6). Thus, CVB3 directly
induced Th17 cell differentiation by promoting acetyl-Stat3-
mediated RORγT synthesis.
DISCUSSION
Early studies showed that CVB3 VP1 directly stimulated T
cell proliferation in vitro (Huber et al., 1993). Kemball et al.
further demonstrated that CVB3 infection directly induced the
differentiation and generation of virus-specific memory CD4+
T cells (Kemball et al., 2009). Nevertheless, our understanding
of the direct effects of CVB3 on CD4+ T cells remains unclear.
In this study, we found that CVB3 was present in CD4+ T cells
of AVMC patients. Moreover, CVB3 entered CD4+ T cells and
directly induced CD4+ T cell differentiation into Th17 cells.
The CAR allows internalization of the CVB3 after attachment
and is the common pathway mediating viral entry into the
cell (Liu and Mason, 2001). However, we found that CAR
was undetectable in nonactivated and activated CD4+ T cells.
DAF, a co-receptor of CAR, is expressed on CD4+ T cells
and facilitates CVB3 internalization by increasing the binding
efficiency of CVB3 on the DAF-CAR complex. Although Patel
et al. considered that the interaction between CVB3 and DAF
alone was insufficient for CVB3 infection (Patel et al., 2009),
Pan et al. indicated that CVB3 infection of human intestinal
epithelial cells without CAR expression was dependent on DAF
(Pan et al., 2015). Furthermore, Martino et al. showed that anti-
DAF mAb blocked coxsackie virus infection of susceptible HeLa
cells by reducing viral adhesion and internalization (Martino
et al., 1998). In this study, we also found that anti-DAF mAb
attenuated CVB3 infection in CD4+ T cells. These data suggested
that the entry of CVB3 into human CD4+ T cells might be
mediated by DAF receptors, not by CAR. In addition, Sims et al.
showed that exosomes significantly enhanced adenoviral entry
in CAR-deficient cells in a receptor-independent fashion (Sims
et al., 2014), which provide another pathway for CVB3 entry
into CD4+ T cells. The precise mechanisms are under further
investigation.
Nup98 is an important nucleoporin mediating nuclear
translocation of mRNAs in viral infection (Enninga et al., 2002).
In the course of investigation of the direct effects of CVB3
on Th17 cells differentiation, we found that Nup98 expression
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FIGURE 6 | Nup98 pathway in Th17 differentiation. (A) Representative pictures for the expressions of p300/CBP, acetyl-Stat3, Stat3, and RORγT in CD4+ T cells
from peripheral blood in AVMC patients with different interventions. Intensity of each band was measured and normalized to the expression of β-actin. (B) Results of
the statistical analysis for the level of Nup98. (C) Results of the statistical analysis for the level of acetyl-Stat3. (D) Results of the statistical analysis for the level of
RORγT and p300/CBP. Values represent means ± SEM. *P < 0.05, **P < 0.01 vs. pcDNA3.1 and NC groups. NC: Nonsilencing siRNA sense.
was decreased while Th17 cell frequencies and IL-17 levels
were increased in AVMC patients. In addition, the CVB3 virus
titers in peripheral CD4+ T cells were positively correlated with
Th17 frequencies in AVMC patients. After CVB3 infection in
vitro, CVB3 infection also reduced the Nup98 expression but
enhanced Th17 cell differentiation and IL-17 secretion. Thus, we
deduced that Nup98 plays a role in CVB3-mediated Th17 cell
differentiation.
To clarify the direct effect of Nup98 on Th17 cell
differentiation, we transfected the pcDNA3.1-Nup98 or siRNA-
Nup98 into CD4+ T cell to overexpress or silence Nup98.
Down-regulation of Nup98 expression facilitated Th17 cell
differentiation and IL-17 secretion, and up-regulation of
Nup98 expression inhibited Th17 cell differentiation and IL-
17 secretion. The findings suggest that CVB3 infection directly
induced Th17 cell differentiation by down- regulation of Nup98
in CD4+ T cells in AVMC.
RORγT is the key transcription factor in Th17 cell
differentiation (Ivanov et al., 2006). Activation of Stat3 leads
to increased expression of orphan nuclear receptors RORγT
for Th17 cell (Chaudhry et al., 2009). Nup98 interacted
with p300/CREB binding protein (CBP) via the region
designated as the FG (Phe–Gly) repeat, which is associated
with RORγT synthesis (Goodman and Smolik, 2000; Ciofani
et al., 2012). Furthermore, the dissociated CBP activated
Stat3 via acetylation. The acetylated-Stat3 is transported
into nucleus to bind with the promoter region of RORγT,
triggering Th17 cell differentiation (Wang et al., 2005). Thus,
we speculated that Nup98/p300/ acetylated-Stat3 pathway
might be involved in CVB3-induced Th17 cell differentiation.
After identifying these signaling molecules, we found that
the siRNA-Nup98 reduced Nup98 expression, attenuated the
binding of Nup98 to CBP, enhanced dissociative CBP levels,
and upregulated acetylated-Stat3, which promoted RORγT
expression. It indicates that CVB3 directly induced Th17 cell
differentiation by promoting acetyl-Stat3-mediated RORγT
synthesis.
In addition, studies suggested that hypoxia-inducible
factor (HIF)-1 recruited p300 and RORγt transcription
complex to IL-17 promoter and facilitated IL-17 production
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(Dang et al., 2011). Thus, we speculated that Nup98
competitively bound to p300 and inhibited the formation
of p300-HIF-RORγt complex, which reduced Th17 cell
differentiation and IL-17 secretion. However, elucidation of
the mechanism underlying these changes needs additional
investigations.
As a limitation of this study, CD4+ T cells were all isolated
from human peripheral blood. Further study about CD4+ T cells
isolated from hearts of myocarditis patients by endomyocardial
biopsy will be more valuable. In addition, there are up to 20
known viruses that may elicit myocarditis (Biesbroek et al., 2015;
Tse et al., 2016). However, we only investigated the direct effect
of CVB3 on Nup98 expression and CD4+ T cell differentiation.
The influences of other viruses on CD4+ T cell differentiation
into Th17 cell needed our further exploration. At the same time,
the influences of CVB3 on the other cytokines related to Th17 cell
such as IL-6, IL-17F, IL-22, and IL-23 are also under investigation.
And the direct effects of CVB3 on Th1 cell need our further
exploration.
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